Respiratory Medicine

Top Story

Cefiderocol noninferior to high-dose meropenem in phase 3 trial for nosocomial pneumonia

Cefiderocol noninferior to high-dose meropenem in phase 3 trial for nosocomial pneumonia
October 4, 2019

Read the Perspective from James A. McKinnell, MD

Meeting News

Nintedanib approval provides 'exciting news' for other CTD-associated ILD

October 1, 2019
SAN DIEGO — A recent FDA approval for systemic sclerosis-associated interstitial lung diseases may portend a new hope for clinicians managing these complicated…
In the JournalsPerspective

Young adults with chronic diseases report more daily marijuana use

September 30, 2019
Patients with medical conditions are more likely to use marijuana than those without, with 11.2% of young adults living with chronic disease using it daily, according to…
Pharmacology Consult

Antihistamines for the common cold: Where’s the evidence?

Infectious Diseases in Children, September 2019
Edward A. Bell, PharmD, BCPS
Recommendations for the treatment of common viral upper respiratory tract infections (URTIs) in children have undergone significant changes over the past 10 years. In…
More Headlines »